CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 102 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06917846
NCT06917846N/ACompleted

Is Medical Therapy Alone Efficient for the Management of Medication-Related Osteonecrosis of the Jaw Bones (MRONJ) in All Stages?: A Comparative Study

Akdeniz University·observational·Posted Apr 9, 2025·Updated Apr 9, 2025

In Brief

An observational study for Osteonecrosis Due to Drugs, Jaw and 2 related conditions. Completed, enrolled 102 participants across 1 site.

Detailed Summary

MRONJ is an acronym used to describe medication-related osteonecrosis of the jaw bones. It has been reported by the AAOMS that bisphosphonates or denosumab can cause this condition. The management of medication-related osteonecrosis of the jaw (MRONJ) is challenging, and there is ongoing debate over whether medical or surgical treatment is the gold standard. The aim of this retrospective study is to investigate the efficacies of medical and surgical treatments of MRONJ and comparatively evaluate their outcomes.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 9, 2025
Enrollment StartJan 1, 2018
Primary CompletionJan 1, 2020
Study CompletionJan 1, 2023
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 1.2 years ago